Table 2 Genotype among cases and controls and their association withT2DN risk.

From: SIRT1 rs10823108 and FOXO1 rs17446614 responsible for genetic susceptibility to diabetic nephropathy

SNP

Case(%)

Control(%)

Pa

OR(95%CI)b

Pb

OR(95%CI)c

Pc

rs3818292

AA

360(55.13)

226(54.72)

 

1

 

1

 

AG

242(37.06)

146(35.35)

 

1.04(0.80, 1.36)

0.770

1.01(0.76, 1.35)

0.940

GG

51(7.81)

41(9.93)

0.26

0.78(0.50, 1.22)

0.270

0.69(0.43, 1.11)

0.120

AG + GG

293(44.87)

187(45.28)

 

0.98(0.77, 1.26)

0.900

0.94(0.72, 1.23)

0.650

AA + AG

602(92.29)

372(90.07)

 

1

 

1

 

GG

51(7.81)

41(9.93)

 

0.77(0.50, 1.18)

 

0.70(0.44, 1.11)

0.120

A

962(73.66)

598(72.40)

 

1

   

G

344(26.34)

228(27.60)

 

0.94(0.77, 1.14)

0.520

  

rs4746720

TT

191(29.25)

121(29.30)

 

1

 

1

 

CT

331(50.69)

210(50.85)

 

0.99(0.75, 1.33)

0.990

0.90(0.66, 1.23)

0.500

CC

131(20.06)

82(19.85)

0.60

1.01(0.71, 1.45)

0.950

1.01(0.69, 1.46)

0.990

CT + CC

462(70.75)

292(70.70)

 

0.98(0.77, 1.26)

0.910

0.92(0.69, 1.23)

0.990

TT + CT

522(79.94)

331(80.15)

 

1

 

1

 

CC

131(20.06)

82(19.85)

 

1.01(0.75, 1.38)

0.940

1.01(0.72, 1.40)

0.970

T

713(54.59)

452(54.72)

 

1

   

C

593(45.41)

374(45.28)

 

1.00(0.84, 1.20)

0.950

  

rs10823108

GG

353(54.06)

224(54.23)

 

1

 

1

 

GA

261(39.97)

148(35.84)

 

1.12(0.86, 1.45)

0.400

1.07(0.81, 1.43)

0.620

AA

39(5.97)

41(9.93)

0.36

0.60(0.38, 0.97)

0.040

0.57(0.34, 0.94)

0.030

GA + AA

300(45.94)

189(45.77)

 

1.01(0.79, 1.29)

0.950

0.97(0.74, 1.27)

0.820

GG + AG

614(94.03)

372(90.07)

 

1

 

1

 

AA

39(5.97)

41(9.93)

 

0.58(0.37, 0.91)

0.020

0.56(0.34, 0.92)

0.020

G

967(74.04)

596(72.15)

 

1

   

A

339(25.96)

230(27.85)

 

0.91(0.75, 1.11)

0.340

  

rs17446614

GG

392(60.03)

304(73.61)

 

1

 

1

 

GA

219(33.54)

95(23.00)

 

1.77(1.33, 2.35)

 < 0.001

1.54(1.14, 2.13)

 < 0.001

AA

42(6.43)

14(3.39)

0.07

2.32(1.25, 4.34)

0.02

2.34(1.77, 4.13)

 < 0.001

GA + AA

261(39.97)

109(26.39)

 

1.86(1.42, 2.43)

 < 0.001

1.65(1.19, 2.26)

 < 0.001

GG + AG

611(93.57)

399(96.61)

 

1

 

1

 

AA

42(6.43)

14(3.39)

 

1.96(1.06, 3.63)

0.03

2.07(1.38, 4.14)

 < 0.001

G

1003(76.80)

703(85.11)

 

1

   

A

303(23.20)

123(14.89)

 

1.73(1.37, 2.18)

 < 0.001

  

rs2721068

TT

77(11.79)

40(9.68)

 

1

 

1

 

CT

296(45.33)

192(46.49)

 

0.80(0.53, 1.22)

0.300

0.64(0.40, 1.02)

0.060

CC

280(42.88)

181(43.83)

0.29

0.81(0.53, 1.23)

0.310

0.73(0.46, 1.15)

0.180

CT + CC

576(88.21)

373(90.32)

 

0.80(0.54, 1.20)

0.280

0.68(0.44, 1.05)

0.080

TT + CT

373(57.12)

232(56.17)

 

1

 

1

 

TT

77(11.79)

40(9.68)

 

0.97(0.75, 1.23)

0.760

0.95(0.73, 1.24)

0.690

T

450(34.46)

272(32.93)

 

1

   

C

856(65.54)

554(67.07)

 

0.93(0.78, 1.12)

0.470

  
  1. aP value of Hardy–Weinberg equilibrium in Controls.
  2. bChi square test for genotype distributions between cases and controls.
  3. cData were calculated by logistic regression analysis with adjusted for age, gender,duration of diabetes, BMI, HbA1C, total cholesterol, triglycerides, HDL-C, LDL-C,history of Hypertension, DM family history, smoking and drinking.